<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00818792</url>
  </required_header>
  <id_info>
    <org_study_id>RENAL-DES</org_study_id>
    <nct_id>NCT00818792</nct_id>
  </id_info>
  <brief_title>Randomized Comparison of xiEnce and visioN Coronary Stents in the sAme muLtivessel Patient With Chronic kiDnEy diSease</brief_title>
  <acronym>RENAL-DES</acronym>
  <official_title>A Multicenter, Randomized Trial to Compare Xience and Vision Coronary Stents in the Same Multivessel Patient With Chronic Kidney Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>European Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>European Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Percutaneous coronary intervention (PCI) with bare metal stent (BMS) in patients with renal
      insufficiency has shown unsatisfactory results. Indeed, drug-eluting stents (DES) might
      reduce the incidence of restenosis and therefore of target lesion revascularization
      procedures in these patients.

      We therefore designed a prospective, randomized, multicenter, not-sponsored study to directly
      compare the efficacy in the prevention of clinical restenosis of everolimus-eluting stent
      (Xience V) and bare-metal stent (Vision) (both 2nd-generation DES and BMS, respectively),
      both implanted in the same patient with multivessel disease and renal insufficiency in order
      to obviate for the multiple and unpredictable characteristics of this high-risk population.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2009</start_date>
  <completion_date type="Actual">September 2012</completion_date>
  <primary_completion_date type="Actual">February 2012</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Ischemia-driven target vessel revascularization</measure>
    <time_frame>9 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Incidence of death and myocardial infarction</measure>
    <time_frame>in-hospital, 30 days, 9 and 12 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">215</enrollment>
  <condition>Chronic Kidney Disease</condition>
  <condition>Multivessel Coronary Artery Disease</condition>
  <arm_group>
    <arm_group_label>Drug-eluting stent Xience V</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Bare-metal stent Vision</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Coronary stent</intervention_name>
    <description>Comparison of bare-metal stent (Vision) and drug-eluting stent (Xience V)</description>
    <arm_group_label>Drug-eluting stent Xience V</arm_group_label>
    <arm_group_label>Bare-metal stent Vision</arm_group_label>
    <other_name>Bare metal stent Vision</other_name>
    <other_name>Drug-eluting stent Xience V</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  chronic renal insufficiency (creatinine clearance &lt;60 ml/min, in dialysis patients
             included) with at least two significant (&gt;70%) coronary lesions in two major coronary
             vessels.

        Exclusion Criteria:

          -  Age &gt;85 years

          -  left main coronary artery disease

          -  saphenous vein graft disease

          -  ST-elevation MI (&lt;3 days)

          -  coronary vessel diameter &lt;2.5 or &gt; 4 mm

          -  contraindication to long-term double antiplatelet therapy

          -  CABG indication by consensus (cardiovascular team)

          -  severe valvular heart disease

          -  informed consent not obtained
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Fabrizio Tomai, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Cardiovascular Sciences, European Hospital, Rome</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>European Hospital</name>
      <address>
        <city>Rome</city>
        <zip>00149</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Azienda Ospedaliera Istituti Ospitalieri di Verona</name>
      <address>
        <city>Verona</city>
        <zip>37126</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <reference>
    <citation>Schiffrin EL, Lipman ML, Mann JF. Chronic kidney disease: effects on the cardiovascular system. Circulation. 2007 Jul 3;116(1):85-97. Review.</citation>
    <PMID>17606856</PMID>
  </reference>
  <reference>
    <citation>Tomai F, Reimers B, De Luca L, Galassi AR, Gaspardone A, Ghini AS, Ferrero V, Favero L, Gioffr√® G, Prati F, Tamburino C, Ribichini F. Head-to-head comparison of sirolimus- and paclitaxel-eluting stent in the same diabetic patient with multiple coronary artery lesions: a prospective, randomized, multicenter study. Diabetes Care. 2008 Jan;31(1):15-9. Epub 2007 Oct 1.</citation>
    <PMID>17909090</PMID>
  </reference>
  <verification_date>January 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 7, 2009</study_first_submitted>
  <study_first_submitted_qc>January 7, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 8, 2009</study_first_posted>
  <last_update_submitted>January 14, 2013</last_update_submitted>
  <last_update_submitted_qc>January 14, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 15, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>European Hospital</investigator_affiliation>
    <investigator_full_name>Fabrizio Tomai</investigator_full_name>
    <investigator_title>MD, FACC, FESC</investigator_title>
  </responsible_party>
  <keyword>Percutaneous coronary intervention</keyword>
  <keyword>Drug-eluting stent</keyword>
  <keyword>Chronic kidney disease</keyword>
  <keyword>Restenosis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Kidney Diseases</mesh_term>
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
    <mesh_term>Coronary Disease</mesh_term>
    <mesh_term>Renal Insufficiency, Chronic</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

